Regencell Bioscience Holdings Ltd (ticker: RGC) is an NASDAQ-listed us cannabis company. DredgeCap's structured extraction of RGC's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. RGC reported no tagged revenue in revenue and -$3.58M for the period ending 2025-06-30, with operating cash flow of -$3.11M. Cash and equivalents stood at $2.42M (down 18.3% year-over-year). Total assets of $5.76M exceed total liabilities of $895K. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
RGC Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Regencell Bioscience Holdings Ltd (RGC) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.